F.D.A. Approves First U.S. Over-the-Counter Birth Control Pillnews2023-07-13T14:32:37+00:00July 13th, 2023|The New York Times|
Why The F.D.A. Should Move Birth Control Over the Counternews2023-05-22T14:28:45+00:00May 22nd, 2023|The New York Times|
Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptivanews2023-05-13T09:00:31+00:00May 13th, 2023|The New York Times|
What an Over-the-Counter Birth Control Pill Could Mean for Younews2023-05-10T19:54:43+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risksnews2023-05-10T17:21:21+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pillnews2023-05-10T12:33:32+00:00May 10th, 2023|The New York Times|
The F.D.A. Now Says It Plainly: Morning-After Pills Are Not Abortion Pillsnews2022-12-24T01:22:45+00:00December 24th, 2022|The New York Times|
F.D.A. to Weigh Over-the-Counter Sale of Birth Control Pillsnews2022-07-11T22:47:25+00:00July 11th, 2022|The New York Times|
What the Biden Administration Could Do Now to Protect Abortion Rightsnews2022-07-08T23:40:08+00:00July 8th, 2022|The New York Times|
